Molsiton Tablet 2 mg (Molsidomine)

Adult dose

The usual initial dose of molsidomine is 1 ～ 2 mg orally 2 ～ 3 times daily after meals; if necessary, the dose may be increased to 4 mg 3 times daily. For the treatment of severe angina, start with molsidomine 4 mg orally 2 ～ 3 times daily after meals.

Child dose

Use is not recommended for children and adolescents under 18 years of age.

This drug should not be used by certain patients. For example, individuals who have had allergic reactions or hypersensitivity to this medication or its ingredients, or those with serious heart or blood circulation issues should avoid it. Caution is also needed for patients with very low blood pressure or in shock, as well as those taking other medications that may interact with this drug. This medication is not recommended for breastfeeding individuals. When taking this drug, especially exercise caution with specific heart conditions such as heart valve disease or recent myocardial infarction, as it contains pigments that may cause allergic reactions, and those with a history of allergies should be careful. Mild side effects such as headaches or dizziness may occur initially, as well as rare side effects like low blood pressure or digestive disturbances. Severe allergic reactions may occur, so if any unusual symptoms persist or worsen, immediate consultation with medical personnel is advised. If severe hypotension or shock symptoms occur, the medication should be stopped, and appropriate treatment should be sought. This drug has a slow onset of action and is not suitable for emergency treatment of acute cardiac problems. Caution is needed when combined with antihypertensive drugs, specific heart medications, or alcohol, as it may lead to excessively low blood pressure. Pregnant or nursing women should not take this drug. In case of overdose, severe hypotension or coma may occur, requiring immediate emergency treatment. This drug should be kept in a safe place away from the reach of children and should not be transferred to a different container. Lastly, while some side effects were reported in animal studies related to overdose, no carcinogenic risk to humans has been established so far.

• headache
• dizziness
• hypotension
• low blood pressure
• orthostatic hypotension
• ischemic conditions
• shock
• orthostatic dysregulation
• reflex tachycardia
• nausea

This medication may be sensitive to light, so it should be stored in a light-protected container. Additionally, it is important to keep it in a sealed container to avoid contact with air. The storage temperature should be maintained at room temperature, not too hot or too cold.

Appearance

Orange round tablet

Package unit

100 tablets/box[(10 tablets/PTP*10)], 300 tablets/bottle